 WORCESTER, Mass., April 04, 2022 GLOBE NEWSWIRE -- Mustang Bio, Inc. Mustang NASDAQ: MBIO, a clinical-stage biopharmaceutical company focused on translating todays medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that members of Mustangs management team will participate in the two-day Fortress Biotech Fortress Virtual RD Summit taking place on Tuesday, April 5, 2022 and Wednesday, April 6, 2022. The Summit will be hosted by the B. Riley Securities Healthcare Equity Research team and will feature multiple programs from Fortress diversified pipeline. 